e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
Silke van Koningsbruggen-Rietschel, Fiona Dunlevy, Veerle Bulteel, Damian G. Downey, Lieven Dupont
Source:
Eur Respir J, 56 (3) 2002114; 10.1183/13993003.02114-2020
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Silke van Koningsbruggen-Rietschel, Fiona Dunlevy, Veerle Bulteel, Damian G. Downey, Lieven Dupont. SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network. Eur Respir J, 56 (3) 2002114; 10.1183/13993003.02114-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
How to accelerate bringing new drugs to patients: role of clinical trials networks
Source: International Congress 2019 – Rare lung diseases
Year: 2019
Key role of patients in clinical trials
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013
Establishing new treatments: the role of RCTs
Source: Virtual Congress 2020 – Tuberculosis: learning from the WHO global health emergencies
Year: 2020
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014
The impact of embedding trial recruitment into a clinical care pathway
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021
Patient-ventilator interaction: assessment and clinical relevance
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
A critical evaluation of the relevance of different asthma phenotypes for clinical practice
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009
The disease model: implications for clinical practice
Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018
Year: 2018
A systematic review to assess the components of clinical decision support systems (CDSS) in chronic respiratory disease (CRD) and their relevance to physiotherapy management
Source: Virtual Congress 2021 – Digital health interventions in respiratory medicine
Year: 2021
Do marker states improve measurement properties of utility instruments: a randomized multi-center trial in patients with chronic respiratory disease
Source: Eur Respir J 2004; 24: Suppl. 48, 295s
Year: 2004
Impact of FVC/SVC relationship and TLC/VA relationship on biologic quality control CV in a large multi-centre clinical trial
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009
The way forward: how to link real-life situations and clinical trial results
Source: Annual Congress 2013 - Lunchtime Session "Tiotropium soft mist inhaler and mortality in COPD: results of the TIOSPIR clinical trial"
Year: 2013
The impact of a new recruitment strategy to improve recruitment of participants to research studies
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019
COPD integrated disease management, from controlled trial to real-world primary care; a cohort study.
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020
Cluster randomised controlled trial of the effect of introduction of an acute wheeze/asthma integrated care pathway on patient outcome
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006
The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018
Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects
Source: International Congress 2017 – In the frontline of the fight against tuberculosis
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept